Drug Trial Radar · NCT00151515
A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
Last checked: Nov 20, 2026Latest source record: Sep 30, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
352
Actual
Start
Oct 2003
Primary completion
Jul 2004
Study completion Jul 2004
Sponsor
- Lead sponsor
- Johnson & Johnson Consumer and Personal Products WorldwideJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 15 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the efficacy of a topical 5% minoxidil formulation in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of a topical 5% minoxidil formulation in males when used twice daily for the treatment of pattern hair loss and to obtain the safety data on the investigational product when used twice daily for up to one year.
Conditions
- Androgenetic Alopecia
Interventions
minoxidilDrug
Topical 5% minoxidil foam, BID, for sixteen weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in non-vellus hair count in the target region as determined by validated computer-assisted dot-mapping technique and subject ratingsTime frame: Baseline to 16 Weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
La Jolla, California
Pfizer Investigational Site
San Francisco, California
Pfizer Investigational Site
Vallejo, California
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
New Haven, Connecticut
Pfizer Investigational Site
Fridley, Minnesota
Pfizer Investigational Site
Minneapolis, Minnesota
Pfizer Investigational Site
Durham, North Carolina
Pfizer Investigational Site
Cincinnati, Ohio
Pfizer Investigational Site
Cleveland, Ohio
Pfizer Investigational Site
Portland, Oregon
Pfizer Investigational Site
Hershey, Pennsylvania
Pfizer Investigational Site
Austin, Texas
Pfizer Investigational Site
Dallas, Texas
Pfizer Investigational Site
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.